Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease.
about
Lung microbiology and exacerbations in COPDCOPD exacerbations. 4: PreventionHuman β-defensin-2 production upon viral and bacterial co-infection is attenuated in COPD.Bronchiectasis in COPD patients: more than a comorbidity?Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial.A new short-term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis.Potentially pathogenic airway bacteria and neutrophilic inflammation in treatment resistant severe asthma.Significance of the microbiome in chronic obstructive pulmonary disease.Colour of sputum is a marker for bacterial colonisation in chronic obstructive pulmonary disease.Pneumocystis jirovecii colonization is associated with enhanced Th1 inflammatory gene expression in lungs of humans with chronic obstructive pulmonary disease.The effect of azithromycin in adults with stable neutrophilic COPD: a double blind randomised, placebo controlled trial.Inflammatory thresholds and the species-specific effects of colonising bacteria in stable chronic obstructive pulmonary disease.Lower airway colonization and inflammatory response in COPD: a focus on Haemophilus influenzaeMicrobiome diversity in the bronchial tracts of patients with chronic obstructive pulmonary disease.Evaluation of glucocorticoid receptor function in COPD lung macrophages using beclomethasone-17-monopropionate.Smoking cessation therapy with vareniclineOxidative stress decreases functional airway mannose binding lectin in COPDChronic obstructive pulmonary disease: the clinical management of an acute exacerbation.Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.Patients with chronic obstructive pulmonary disease and chronically colonized with Haemophilus influenzae during stable disease phase have increased airway inflammationAnalysis of microbiota in stable patients with chronic obstructive pulmonary disease.Chronic obstructive pulmonary disease, pollution, pulmonary vascular disease, transplantation, pleural disease, and lung cancer in AJRCCM 2003.Quantitative analysis of pathogens in the lower respiratory tract of patients with chronic obstructive pulmonary diseaseImpaired Innate COPD Alveolar Macrophage Responses and Toll-Like Receptor-9 Polymorphisms.The lung tissue microbiome in chronic obstructive pulmonary disease.Community dynamics and the lower airway microbiota in stable chronic obstructive pulmonary disease, smokers and healthy non-smokers.Convergence of the epidemiology and pathology of COPDInflammatory cells in the airways in COPD.Patients with cystic fibrosis have inducible IL-17+IL-22+ memory cells in lung draining lymph nodes.Role of infection and antimicrobial therapy in acute exacerbations of chronic obstructive pulmonary disease.COPD exacerbations . 2: aetiologyOutcome in adult bronchiectasis.Pneumocystis: a novel pathogen in chronic obstructive pulmonary disease?Role of N-acetylcysteine in the management of COPDGenetic predisposition to accelerated decline of lung function in COPDAirway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease.Impaired alveolar macrophage response to Haemophilus antigens in chronic obstructive lung disease.Inhibition of lipopolysaccharide-stimulated chronic obstructive pulmonary disease macrophage inflammatory gene expression by dexamethasone and the p38 mitogen-activated protein kinase inhibitor N-cyano-N'-(2-{[8-(2,6-difluorophenyl)-4-(4-fluoro-2-meCOPD phenotype description using principal components analysis.Gender differences in the association between C-reactive protein, lung function impairment, and COPD.
P2860
Q22305860-D9EC5A79-2C10-4A79-BDF8-63389E61BA4AQ30480789-C4A349D6-DBAF-4472-8486-B086B7664664Q33657752-67619170-4277-4B00-93BE-CA581F67ED8EQ33704105-AC4BB17A-9DDD-4D3E-8DB5-B439AE1550E4Q33711672-FAC5A341-9B90-4BB9-B719-4DB9964BC1DDQ33768450-61015635-2F20-4B0C-93D4-485090139A11Q33793577-1F622C45-A410-4727-9B0F-9C974D8774FBQ33817613-93EC9143-C6A7-4440-8552-40E6D75275B9Q33905336-BADC59D6-C1FC-406E-8473-3BF39DEA0003Q33933207-BEF418DB-A590-44FC-92BA-86C3C0C013A1Q34078696-5848C806-AE23-4F3A-9E13-13F2E64F009DQ34234995-DD77C5B0-A9CB-412C-BCCD-0564E175A98CQ34386841-98C3D7D0-E23A-45D1-B8EC-F06323E56124Q34390389-CDFD1DB2-B04C-4AB5-8711-5A476360664AQ34738020-3F99C48F-6A85-48A0-9FF7-457158666D8CQ34805380-539D33B1-3FB6-4D8B-8CCD-C9F5F566E8E0Q35182269-97559AAF-4172-4EFA-BCC2-EFD6640A20E1Q35520406-03F3246B-9508-4FF8-B352-134D3B8A8A21Q35537270-CFC4016F-3266-4863-80AA-12D678F8684CQ35594061-8141DE14-7DDC-4D0F-A0FB-6A44C0E5BE8AQ35598658-FECEAF8E-3A46-451E-9AD7-A0618861D9ABQ35626624-3FBEF0F6-5078-4183-8D03-A6F380E6243CQ35749457-EECFF20D-E750-4FA7-816A-8F4752553A54Q35771023-8978521A-71FF-44B9-8D3D-0992B7CC7DD4Q35987112-55D095A1-37C3-482B-B77C-88383A76092BQ36008670-98B1E141-FAC6-49C1-BCA8-BA06A9BFBB23Q36148610-3956A33A-CD65-454F-BD9F-E09AEB4AA54FQ36203075-2E65BAE8-6DAB-464A-B963-9BCA33F5F2B1Q36368544-442D1435-48D7-43B7-A363-D839BC00C666Q36379352-5D5E9800-3F67-479F-9873-3E49FD15E47CQ36414253-A9933FFE-368D-4EAE-BDDD-95ED6F86B880Q36669411-1CF02F22-B0A9-4286-8841-FD97B08231FBQ37014972-52CA8D1C-DDEC-4FA4-A56F-36D6E8D60288Q37017349-29BBACD8-A0D2-414F-B0AC-98C2ACFF1356Q37017524-07A7C3B5-9F4E-420A-B3BA-DA4572B1B462Q37144323-71632483-63AA-4EC4-9D84-4BE42CA185F0Q37144335-3E592C8D-C8E7-4E3A-A25E-7C01F9F569B9Q37192755-920DACB0-3B9B-403D-9A24-266AC0C85F34Q37233745-9EDFD6EA-6A2E-4CAD-8FDF-408E91C1B8B7Q37236587-01B22F39-0EA5-4A47-9B31-90C0B7F44FE1
P2860
Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Airway bacterial load and FEV1 ...... obstructive pulmonary disease.
@en
Airway bacterial load and FEV1 ...... obstructive pulmonary disease.
@nl
type
label
Airway bacterial load and FEV1 ...... obstructive pulmonary disease.
@en
Airway bacterial load and FEV1 ...... obstructive pulmonary disease.
@nl
prefLabel
Airway bacterial load and FEV1 ...... obstructive pulmonary disease.
@en
Airway bacterial load and FEV1 ...... obstructive pulmonary disease.
@nl
P2093
P2860
P1476
Airway bacterial load and FEV1 ...... obstructive pulmonary disease.
@en
P2093
Gavin C Donaldson
Irem S Patel
Jadwiga A Wedzicha
Mark Wilks
Tom M A Wilkinson
P2860
P304
P356
10.1164/RCCM.200210-1179OC
P407
P577
2003-01-24T00:00:00Z